Developer docs
API playgroundTry for free, no card

Search company profiles

Myota

Full company profile

uuid0003mhw

Namestring
Myota
Legal namestring
Myota Limited
Websiteurl
hellomyota.com
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
prebiotic fibre supplements, gut health products, microbiome interventions, dietary supplement blends, functional fibre nutrition
Industry1 code
PRIMARYCRADAGAF
Probiotics & Digestive Health Supplements
NAICS code2 codes
  • Food Manufacturing311
  • Food (Health) Supplement Retailers456191
SIC code2 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Prebiotic Supplements
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Revenue
TypeSubscription Recurring
Description

Monthly and quarterly subscription plans for fibre blend products with recurring billing. Subscribers receive free shipping and discounted rates compared to one-time purchases.

hellomyota.com
2One-time Product Sales
TypeOne Time License
Description

Single purchase options for fibre blends (1-month supply) and bundles (3-month packs) at regular pricing without subscription discounts.

hellomyota.com
3Bundle and Cross-sell Revenue
TypeOne Time License
Description

Bundled products combining fibre blends with prebiotic fibre bars at discounted package prices, offering savings versus individual purchases.

hellomyota.com
4Gift Cards
TypeOne Time License
Description

Digital gift cards sold in denominations of £45, £120, and £220 for gifting the product to others.

hellomyota.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations, Infrastructure
Pricing details7 tiers
1Gut Health fibre blend subscription - £37.50/month with 10% subscriber discount
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly subscription at £37.50 (save 10% vs one-time). One-time purchase: £69/month. Includes free starter kit with 3-month trial offer at 35% off.

hellomyota.com
2Metabolic Health fibre blend subscription - £37.50/month with 10% subscriber discount
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly subscription at £37.50 (save 10% vs one-time). One-time purchase option available.

hellomyota.com
33-Month Gut Reset Trial - £1.08/day (approximately £97.50 for 90 servings)
ModelSubscriptionBilling cadenceMulti-year contract
Notes

35% off promotional offer for new customers. Includes free starter kit worth £38 (drinking bottle, storage tin, metal spoon, free shipping). Regular price £150.

hellomyota.com
4Prebiotic Fibre Bars - £2 per bar or £41 for 15-bar box
ModelUnit PricingBilling cadencePay-as-you-go
Notes

On-the-go bars with over 12g fibre per bar (40% daily value). Available in Apple & Cinnamon and Peanut Butter & Chocolate flavours.

hellomyota.com
51-Month Gut Health Bundle - £42.50 (15% off)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Includes 30 days of fibre (£50 value) plus 15 high fibre bars (£30 value) for £42.50. One-time purchase option.

hellomyota.com
63-Month Metabolic Health Bundle - £147 (30% off, save £68)
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Includes 90 days of fibre (£150 value) plus 30 high fibre bars (£60 value) for £147. Save £68 compared to individual prices.

hellomyota.com
7Digital Gift Cards - £45, £120, £220 denominations
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Digital gift cards available in three denominations: £45, £120, £220. The gift of a happy gut.

hellomyota.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Myota develops and sells patented prebiotic fibre blend supplements (Gut Health and Metabolic Health variants) along with prebiotic fibre bars and a gut microbiome test kit. The blends combine 5-8 plant-based fibres that ferment in the gut to produce short-chain fatty acids (SCFAs) and are clinically proven to improve digestive regularity, reduce blood sugar spikes by 28%, lower cholesterol, and support immune, heart, brain and metabolic health. Products are sold direct-to-consumer via subscriptions and one-time purchases on myotahealth.com, plus supplied as B2B ingredients to food and beverage companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 28% reduction in blood sugar spikes when taking Myota with a meal
+4 more records
Product overview1 text field

Myota is a gut health company offering scientifically-formulated prebiotic fibre supplements. The product portfolio consists of two core fibre blend powders (Gut Health and Metabolic Health) designed for different health goals, Prebiotic Fibre Bars for on-the-go consumption, a Gut Microbiome Test Kit that provides personalized recommendations, and Digital Gift Cards. All products are developed in partnership with MIT and Cambridge University researchers, featuring patented, clinically-proven fibre blend formulations that target the gut microbiome to produce short-chain fatty acids (SCFAs) for overall health benefits.

Product and service5 records
1Gut Health fibre blend
CategoryPrebiotic fibre supplement
Description

A vegan, low FODMAP certified blend of 5 natural prebiotic fibres designed to restore balance in the gut, relieve digestive symptoms, reduce bloating, cramps, and irregularity. Clinically proven to improve gut health and regularity. Sold via subscription (£37.50/month) or one-time purchase.

2Metabolic Health fibre blend
CategoryPrebiotic fibre supplement
Description

A vegetarian, gluten-free blend of 8 plant-based fibres formulated to support gut, heart, and brain health. Designed to reduce mid-afternoon energy slumps, cravings, and lack of focus. Sold via subscription (£37.50/month) or one-time purchase.

3Prebiotic Fibre Bars
CategoryFunctional snack food
Description

On-the-go snack bars with over 12g of natural plant-based fibres per bar (40% of recommended daily intake). Available in Apple & Cinnamon and Peanut Butter & Chocolate flavours. Certified gluten-free and vegan. Priced at £2 per bar or £41 for a 15-bar box.

4Gut Microbiome Test Kit
CategoryDiagnostic test kit
Description

A stool sample test kit that analyzes gut microbiome composition and fermentation capability to provide personalized fibre-rich food recommendations. Described as the first and only test that reveals how gut bacteria break down different types of fibre to produce SCFAs.

5Digital Gift Card
CategoryGift product
Description

Digital gift cards available in £45, £120, and £220 denominations, allowing recipients to purchase Myota fibre blends and related products.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Over a decade of research conducted at MIT's labs. Products developed by scientists who conducted groundbreaking gut microbiome research at MIT. Dr. Thomas Gurry completed PhD research at MIT's Computational Biophysics Group and served as Postdoctoral researcher at MIT Center for Microbiome Informatics and Therapeutics.

2Cambridge University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership for microbiome and fibre fermentation research. Listed as a research partner on the Myota website alongside MIT.

hellomyota.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partnership where Dr. Thomas Gurry served as Senior Research Associate. Research on fibre fermentation by the gut microbiome conducted in collaboration with the university.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership with Dr. Caitlin Hall completing PhD in Gut-Brain Axis Microbiology at this institution. Partnership for gut microbiome and mental health research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical trials conducted in partnership with NHS trusts for Type 2 diabetes research and pilot studies to treat IBS. Products trusted by NHS clinicians, demonstrating clinical credibility and regulatory acceptance.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Caitlin Hall conducted PhD research in Gut-Brain Axis Microbiology at QIMR Berghofer in Australia, establishing an academic research connection.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Thomas Gurry serves as Consultant at Aiven Partners LLC alongside his role at Myota, representing an industry advisory connection.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based DTC microbiome company selling synbiotic (probiotic + prebiotic) supplements with a science-led brand narrative. Directly comparable to Myota in the consumer gut-health subscription category with overlapping target customers and clinician-endorsed positioning.

TypeDirect peer
Description

DTC microbiome company focused on metabolic health (blood sugar, glucose control) using patented probiotic strains. Comparable to Myota in combining clinical evidence, patented formulations, and direct-to-consumer subscription distribution targeting the metabolic/gut-health overlap.

TypeDirect peer
Description

Personalised nutrition company offering gut microbiome testing combined with food and supplement recommendations. Directly comparable to Myota's combination of microbiome test kit, personalised recommendations, and DTC subscription model.

TypeDirect peer
Description

Premium DTC vitamins and supplements brand positioned around traceability, clinical evidence, and minimal-ingredient formulations. Comparable to Myota in the science-backed, subscription-based DTC supplement category targeting health-conscious consumers.

5AG1 (Athletic Greens)
TypeBroad incumbent
Description

Larger and more established DTC daily-nutrition brand with a comprehensive greens/supplement formulation. Comparable to Myota as a science-led DTC nutrition subscription at higher scale and broader scope (full-spectrum supplement vs. targeted prebiotic).

6BioGaia
TypeBroad incumbent
Description

Swedish probiotic supplement company with clinically documented Lactobacillus strains sold via healthcare professionals and OTC. Comparable to Myota in clinically validated microbiome products, though broader in scope (probiotics not prebiotics) and B2B/B2C hybrid.

TypeDirect peer
Description

UK-based probiotic supplement brand with live bacteria formulations targeting gut health, IBS, and digestive issues. Comparable to Myota as a UK-headquartered, science-supported gut-health brand competing for the same UK consumer and pharmacy channel.

8Optibac Probiotics
TypeDirect peer
Description

UK probiotic specialist offering strain-specific supplements for gut, IBS, and immune health with practitioner endorsements. Comparable to Myota in clinical positioning, UK distribution, and use of healthcare professional referrals to drive consumer demand.

TypeOthers
Description

Global B2B food ingredient supplier with a significant portfolio of soluble fibres (including prebiotic fibres such as FOS and polydextrose). Comparable to Myota as a B2B supplier of prebiotic fibre ingredients into food and beverage manufacturers.

TypeOthers
Description

Südzucker subsidiary specialising in functional food ingredients including inulin, FOS, and other prebiotic fibres. Comparable to Myota as a B2B ingredient provider of the same fibre categories (FOS, inulin) that form the core of Myota's patented blends.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Myota

Prebiotic Supplementshellomyota.com

Myota firmographics

Firmographics
Name
Myota
Legal name
Myota Limited
Website
https://hellomyota.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Myota industry classification

Industry
Product category
Prebiotic Supplements
NAICS
Food Manufacturing (311), Food (Health) Supplement Retailers (456191)
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro industry
PRIMARYCRADAGAF
Probiotics & Digestive Health Supplements

Keywords

  • Prebiotic fibre supplements
  • Gut health products
  • Microbiome interventions
  • Dietary supplement blends
  • Functional fibre nutrition

Where Myota is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Myota business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations, Infrastructure

Revenue model

  1. Subscription Revenue: Monthly and quarterly subscription plans for fibre blend products with recurring billing. Subscribers receive free shipping and discounted rates compared to one-time purchases.
  2. One-time Product Sales: Single purchase options for fibre blends (1-month supply) and bundles (3-month packs) at regular pricing without subscription discounts.
  3. Bundle and Cross-sell Revenue: Bundled products combining fibre blends with prebiotic fibre bars at discounted package prices, offering savings versus individual purchases.
  4. Gift Cards: Digital gift cards sold in denominations of £45, £120, and £220 for gifting the product to others.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyGut Health fibre blend subscription - £37.50/month with 10% subscriber discount
SubscriptionMonthlyMetabolic Health fibre blend subscription - £37.50/month with 10% subscriber discount
SubscriptionMulti-year contract3-Month Gut Reset Trial - £1.08/day (approximately £97.50 for 90 servings)
Unit PricingPay-as-you-goPrebiotic Fibre Bars - £2 per bar or £41 for 15-bar box
SubscriptionPay-as-you-go1-Month Gut Health Bundle - £42.50 (15% off)
SubscriptionMulti-year contract3-Month Metabolic Health Bundle - £147 (30% off, save £68)
One time/ perpetual licensePay-as-you-goDigital Gift Cards - £45, £120, £220 denominations

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Myota product offering

Product offering

Core offering

Myota develops and sells patented prebiotic fibre blend supplements (Gut Health and Metabolic Health variants) along with prebiotic fibre bars and a gut microbiome test kit. The blends combine 5-8 plant-based fibres that ferment in the gut to produce short-chain fatty acids (SCFAs) and are clinically proven to improve digestive regularity, reduce blood sugar spikes by 28%, lower cholesterol, and support immune, heart, brain and metabolic health. Products are sold direct-to-consumer via subscriptions and one-time purchases on myotahealth.com, plus supplied as B2B ingredients to food and beverage companies.

Product overview

Myota is a gut health company offering scientifically-formulated prebiotic fibre supplements. The product portfolio consists of two core fibre blend powders (Gut Health and Metabolic Health) designed for different health goals, Prebiotic Fibre Bars for on-the-go consumption, a Gut Microbiome Test Kit that provides personalized recommendations, and Digital Gift Cards. All products are developed in partnership with MIT and Cambridge University researchers, featuring patented, clinically-proven fibre blend formulations that target the gut microbiome to produce short-chain fatty acids (SCFAs) for overall health benefits.

Differentiator

Problem solved

Functional benefit

Products and services

  • Gut Health fibre blend A vegan, low FODMAP certified blend of 5 natural prebiotic fibres designed to restore balance in the gut, relieve digestive symptoms, reduce bloating, cramps, and irregularity. Clinically proven to improve gut health and regularity. Sold via subscription (£37.50/month) or one-time purchase.
  • Metabolic Health fibre blend A vegetarian, gluten-free blend of 8 plant-based fibres formulated to support gut, heart, and brain health. Designed to reduce mid-afternoon energy slumps, cravings, and lack of focus. Sold via subscription (£37.50/month) or one-time purchase.
  • Prebiotic Fibre Bars On-the-go snack bars with over 12g of natural plant-based fibres per bar (40% of recommended daily intake). Available in Apple & Cinnamon and Peanut Butter & Chocolate flavours. Certified gluten-free and vegan. Priced at £2 per bar or £41 for a 15-bar box.
  • Gut Microbiome Test Kit A stool sample test kit that analyzes gut microbiome composition and fermentation capability to provide personalized fibre-rich food recommendations. Described as the first and only test that reveals how gut bacteria break down different types of fibre to produce SCFAs.
  • Digital Gift Card Digital gift cards available in £45, £120, and £220 denominations, allowing recipients to purchase Myota fibre blends and related products.

Quantifiable outcome

  • 28% reduction in blood sugar spikes when taking Myota with a meal
  • +4 more outcomes

Companies that use Myota

Customer profile

Named customers2 records

Segments6 records

Ideal customer profiles2 records

Myota technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Myota partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • MIT (Massachusetts Institute of Technology)coreStrategic or Co-development PartnerOver a decade of research conducted at MIT's labs. Products developed by scientists who conducted groundbreaking gut microbiome research at MIT. Dr. Thomas Gurry completed PhD research at MIT's Computational Biophysics Group and served as Postdoctoral researcher at MIT Center for Microbiome Informatics and Therapeutics.
  • Cambridge UniversitycoreStrategic or Co-development PartnerResearch partnership for microbiome and fibre fermentation research. Listed as a research partner on the Myota website alongside MIT.
  • University of GenevacoreStrategic or Co-development PartnerAcademic research partnership where Dr. Thomas Gurry served as Senior Research Associate. Research on fibre fermentation by the gut microbiome conducted in collaboration with the university.
  • King's College LondoncoreStrategic or Co-development PartnerResearch partnership with Dr. Caitlin Hall completing PhD in Gut-Brain Axis Microbiology at this institution. Partnership for gut microbiome and mental health research.
  • NHS (National Health Service)coreStrategic or Co-development PartnerClinical trials conducted in partnership with NHS trusts for Type 2 diabetes research and pilot studies to treat IBS. Products trusted by NHS clinicians, demonstrating clinical credibility and regulatory acceptance.
  • QIMR Berghofer (Medical Research Institute)minorStrategic or Co-development PartnerDr. Caitlin Hall conducted PhD research in Gut-Brain Axis Microbiology at QIMR Berghofer in Australia, establishing an academic research connection.
  • Aiven Partners LLCminorStrategic or Co-development PartnerDr. Thomas Gurry serves as Consultant at Aiven Partners LLC alongside his role at Myota, representing an industry advisory connection.

Scale indicators9 records

Recent moves5 records

Expansion highlights6 records

Myota competitors and assessment

Company assessment

Direct peers

  • Seed Health: US-based DTC microbiome company selling synbiotic (probiotic + prebiotic) supplements with a science-led brand narrative. Directly comparable to Myota in the consumer gut-health subscription category with overlapping target customers and clinician-endorsed positioning.
  • Pendulum: DTC microbiome company focused on metabolic health (blood sugar, glucose control) using patented probiotic strains. Comparable to Myota in combining clinical evidence, patented formulations, and direct-to-consumer subscription distribution targeting the metabolic/gut-health overlap.
  • ZOE: Personalised nutrition company offering gut microbiome testing combined with food and supplement recommendations. Directly comparable to Myota's combination of microbiome test kit, personalised recommendations, and DTC subscription model.
  • Ritual: Premium DTC vitamins and supplements brand positioned around traceability, clinical evidence, and minimal-ingredient formulations. Comparable to Myota in the science-backed, subscription-based DTC supplement category targeting health-conscious consumers.
  • Bio-Kult: UK-based probiotic supplement brand with live bacteria formulations targeting gut health, IBS, and digestive issues. Comparable to Myota as a UK-headquartered, science-supported gut-health brand competing for the same UK consumer and pharmacy channel.
  • Optibac Probiotics: UK probiotic specialist offering strain-specific supplements for gut, IBS, and immune health with practitioner endorsements. Comparable to Myota in clinical positioning, UK distribution, and use of healthcare professional referrals to drive consumer demand.

Broad incumbents

  • AG1 (Athletic Greens): Larger and more established DTC daily-nutrition brand with a comprehensive greens/supplement formulation. Comparable to Myota as a science-led DTC nutrition subscription at higher scale and broader scope (full-spectrum supplement vs. targeted prebiotic).
  • BioGaia: Swedish probiotic supplement company with clinically documented Lactobacillus strains sold via healthcare professionals and OTC. Comparable to Myota in clinically validated microbiome products, though broader in scope (probiotics not prebiotics) and B2B/B2C hybrid.

Others

  • Tate & Lyle: Global B2B food ingredient supplier with a significant portfolio of soluble fibres (including prebiotic fibres such as FOS and polydextrose). Comparable to Myota as a B2B supplier of prebiotic fibre ingredients into food and beverage manufacturers.
  • BENEO: Südzucker subsidiary specialising in functional food ingredients including inulin, FOS, and other prebiotic fibres. Comparable to Myota as a B2B ingredient provider of the same fibre categories (FOS, inulin) that form the core of Myota's patented blends.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Myota social profiles

Digital presence

Myota compliance and trust

Trust signal

Compliance6 records

Myota financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Myota leadership team

Management profile

Number of profiles

Profiles2 records

Myota funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Myota M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Myota

What does Myota do?

Myota develops and sells patented prebiotic fibre blend supplements (Gut Health and Metabolic Health variants) along with prebiotic fibre bars and a gut microbiome test kit. The blends combine 5-8 plant-based fibres that ferment in the gut to produce short-chain fatty acids (SCFAs) and are clinically proven to improve digestive regularity, reduce blood sugar spikes by 28%, lower cholesterol, and support immune, heart, brain and metabolic health. Products are sold direct-to-consumer via subscriptions and one-time purchases on myotahealth.com, plus supplied as B2B ingredients to food and beverage companies.

Is Myota a public or private company?

Myota is a private company. It is classified as venture growth investor backed and is currently operating.

When was Myota founded?

Myota was founded in 2014. It employs 1 to 10 people.

Where is Myota based?

Myota is headquartered in London, United Kingdom, in the Europe region.

How does Myota make money?

Four revenue lines are on record. Subscription Revenue is the primary driver. The others are one-time Product Sales, bundle and Cross-sell Revenue and gift Cards.

Who are Myota's main competitors?

Direct peers on record are Seed Health, Pendulum, ZOE, Ritual, Bio-Kult and Optibac Probiotics. Broad incumbents are AG1 (Athletic Greens) and BioGaia. Others are Tate & Lyle and BENEO.

Does Myota have an API?

No public API is recorded for Myota.

What industry is Myota in?

Myota's product category is Prebiotic Supplements. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
nutraingredients.comGrowing demand for evidence-backed fiber drives Myota’s $4.5m funding roundMyota, a company developing fiber blends designed to improve short-chain fatty acid production across different gut microbiomes, has closed a $4.5 million funding round led by PeakBridge. The company plans to use the proceeds to expand B2B sales teams in the US and Europe, scale its direct-to-consumer business, and advance clinical research. The article highlights growing consumer demand for clinically validated fiber ingredients, with investors noting that regulatory and retailer scrutiny of health claims is rising, favouring companies that invested early in clinical evidence.FoundersTodayMyota raises $4.5M Series A to scale Gut Health Ingredients across Food and Wellness MarketsMyota, a health technology company developing patented prebiotic fiber blends backed by clinical research, has raised $4.5M in a Series A round led by PeakBridge. The funding will support scaling of B2B sales operations across the US and Europe, expansion of its direct-to-consumer business, and continued clinical research on its gut health ingredients. The company positions itself to serve food, beverage, food service, and wellness companies seeking clinically validated fiber ingredients with substantiated health claims.StartupriseMyota Raises $4.5 Mn in Series A Round led by PeakBridgeMyota, a company focused on gut health and the microbiome, has raised $4.5 million in a Series A funding round led by PeakBridge. The company will use the funding to grow its B2B sales operations in the U.S. and Europe, expand its direct-to-consumer business, and support additional clinical research on its patented prebiotic fiber blend products. Myota's fiber blends, which have shown results in randomized controlled trials for insulin sensitivity, blood sugar control, inflammation, and mood, are designed to be added to everyday food and drinks and target companies across the food, beverage, and wellness sectors.NutraceuticalsworldMicrobiome Company Myota Raises $4.5 Million Series AMyota, a gut-microbiome company, closed a $4.5 million Series A led by PeakBridge. The funds will support B2B sales in the U.S. and Europe, scale its D2C business, and extend clinical research. The company reports over 60,000 D2C customers and partnerships with brands like Joe & The Juice.GreenqueenUK Gut Health Startup Myota Raises $4.5M to Scale Prebiotic Fibre BlendsUK-based gut health startup Myota has secured $4.5 million in Series A funding led by PeakBridge to expand its direct-to-consumer sales and establish a B2B presence in Europe and the US. The investment will support the scaling of its patented prebiotic fibre blends, which are designed for efficacy across diverse microbiomes, and fund further clinical research. This financial backing follows recent partnerships with brands like Joe & The Juice and distribution deals covering the UK, US, and EU.NeonNEON advises PeakBridge on $4.5 Million Series A of MyotaNEON advised PeakBridge on Myota's $4.5 million Series A financing round. The funding will support Myota's B2B sales operation in the US and Europe, its D2C business, and clinical research. Myota's patented prebiotic fibre blends target gut health in food, supplement, and food service industries.ThegrocerMyota raises $4.5m to supply clinically backed fibre blends to F&B industryGut health supplement brand Myota has closed a $4.5 million Series A fundraise led by VC firm PeakBridge to expand its B2B sales operations and clinical research. The company, which supplies clinically backed prebiotic fibre blends, recently launched a partnership with Joe & The Juice and is developing products for various food and beverage manufacturers.Nutraceutical Business ReviewSuannutra to distribute Myota's prebiotic fibre blends across US, UK and EU marketsNutraceutical giant Suannutra has entered into an exclusive partnership to distribute Myota's prebiotic fibre blends across the US, UK, and EU markets. The agreement covers Myota's product line, including its flagship Metabolic Booster solution, which is supported by research from MIT.British VogueThe Fibre Fix: The Best Supplements For Gut Health And DigestionThe article highlights a selection of fibre supplements designed to help consumers meet recommended daily intake levels for improved gut health and digestion. It provides detailed reviews of specific products from brands including Artah, Myota, Pure Encapsulations, and Loam, outlining their ingredients and purported benefits.nutraingredients.comASA bans Myota’s ads for making unauthorized weight loss claimsThe ASA has banned Myota’s advertisements for making unauthorized weight loss claims about its product, Metabolic Booster, which implied effects similar to prescription GLP-1 drugs. Myota's co-founder stated the company respects the ASA's decision and has taken steps to amend its marketing materials to comply with regulations. The ruling emphasizes the importance of accurate health claims in advertising for food supplements in the UK.